Abstract
Peptides represent an important class of biologically active molecules with high potential for the development of diagnostic and therapeutic agents due to their structural diversity, favourable pharmacokinetic properties, and synthetic availability. However, the widespread use of peptides and conjugates thereof in clinical applications can be hampered by their low stability in vivo due to rapid degradation by endogenous proteases. A promising approach to circumvent this potential limitation includes the substitution of metabolically labile amide bonds in the peptide backbone by stable isosteric amide bond mimetics. In this review, we focus on the incorporation of 1,4-disubstituted 1,2,3-triazoles as amide bond surrogates in linear peptides with the aim to increase their stability without impacting their biological function(s). We highlight the properties of this heterocycle as a trans-amide bond surrogate and summarise approaches for the synthesis of triazole-containing peptidomimetics via the Cu(I)-catalysed azide-alkyne cycloaddition (CuAAC). The impacts of the incorporation of triazoles in the backbone of diverse peptides on their biological properties such as, e.g., blood serum stability and affinity as well as selectivity towards their respective molecular target(s) are discussed.
Subject
Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Rational utilization of 1,2,3-triazole scaffold in anti-MRSA drug development: Design strategies, structural insights and pharmacological outcomes;Journal of Molecular Structure;2024-01
2. 1,2,3-Triazoles in Biomolecular Crystallography: A Geometrical Data-Mining Approach;Journal of Medicinal Chemistry;2023-10-30
3. Trends in the Diversification of the Detergentome;ChemPlusChem;2023-09-28
4. Design, synthesis, conformational analysis, and biological activity of Cα
1
-to-Cα
6
1,4- and 4,1-disubstituted 1
H
-[1,2,3]triazol-1-yl-bridged oxytocin analogues;Journal of Enzyme Inhibition and Medicinal Chemistry;2023-09-21
5. Pathogenesis of Alzheimer’s Disease and Diversity of 1,2,3-Triazole Scaffold in Drug Development: Design Strategies, Structural Insights, and Therapeutic Potential;ACS Chemical Neuroscience;2023-09-08